Pacific Biosciences of California Inc
NASDAQ:PACB
Pacific Biosciences of California Inc
NASDAQ:PACB
Price:
1.83 USD
3.98%
Market Closed
Updated:
May 5, 2024
Pacific Biosciences of California Inc
Operating Income
|
Pacific Biosciences of California Inc
Operating Income Peer Comparison
Comparables:
TMO
DHR
MTD
A
IQV
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Pacific Biosciences of California Inc
NASDAQ:PACB
|
Operating Income
-$322m
|
CAGR 3-Years
-46%
|
CAGR 5-Years
-26%
|
CAGR 10-Years
-15%
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Operating Income
$7.3B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
14%
|
CAGR 10-Years
15%
|
|
|
Danaher Corp
NYSE:DHR
|
Operating Income
$9.5B
|
CAGR 3-Years
20%
|
CAGR 5-Years
26%
|
CAGR 10-Years
12%
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Operating Income
$1.1B
|
CAGR 3-Years
11%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Operating Income
$1.3B
|
CAGR 3-Years
11%
|
CAGR 5-Years
6%
|
CAGR 10-Years
16%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Operating Income
$2.1B
|
CAGR 3-Years
38%
|
CAGR 5-Years
21%
|
CAGR 10-Years
16%
|
See Also
What is Pacific Biosciences of California Inc's Operating Income?
Operating Income
-322m
USD
-322m
USD
Based on the financial report for Dec 31, 2023, Pacific Biosciences of California Inc's Operating Income amounts to -322m USD.
What is Pacific Biosciences of California Inc's Operating Income growth rate?
Operating Income CAGR 10Y
-15%
-15%
Over the last year, the Operating Income growth was -6%. The average annual Operating Income growth rates for Pacific Biosciences of California Inc have been -46% over the past three years , -26% over the past five years , and -15% over the past ten years .
You don't have any saved screeners yet
